Hims & Hers Health, Inc.·4

Jun 17, 6:51 PM ET

Carroll Patrick Harrison 4

4 · Hims & Hers Health, Inc. · Filed Jun 17, 2026

Research Summary

AI-generated summary of this filing

Updated

HIMS CMO Patrick Harrison Receives RSU Shares; Shares Withheld

What Happened

  • Carroll Patrick Harrison, Chief Medical Officer of Hims & Hers Health, had 25,926 restricted stock units (RSUs convert/settle into Class A common shares) vest/convert on June 15, 2026. Of those shares, 8,310 were withheld and sold to cover tax withholding obligations for proceeds of approximately $250,713 (sale price reported at $30.17 per share). The net shares delivered to Harrison after withholding were 17,616 (25,926 gross − 8,310 withheld).
  • This was a vesting/settlement of RSUs (derivative conversion), not an open-market purchase or voluntary sale by the insider; the withholding is a routine tax-related disposition.

Key Details

  • Transaction date: June 15, 2026; Form 4 filed June 17, 2026 (timely filing).
  • Gross shares from RSU settlement: 25,926 shares converted to Class A common stock.
  • Shares withheld/sold for taxes: 8,310 shares at $30.17 per share, totaling ~$250,713.
  • Net shares delivered to insider: 17,616 shares (not a market sell initiated by the insider beyond required tax withholding).
  • Footnotes: RSUs represent contingent rights to one share each; issuer withheld shares to satisfy tax withholding. RSUs are subject to multi-year service-based vesting schedules (see filing footnotes for grant-specific vesting start dates).
  • Shares owned after the transaction: Not specified in this Form 4.

Context

  • This is a routine RSU vesting and tax-withholding transaction. When RSUs settle, companies commonly withhold or sell a portion of shares to cover payroll/tax obligations; that action should not be read as a voluntary "sell" indicating changed insider sentiment.
  • The filing shows a derivative conversion (M code) and a tax-withholding disposition (F code). The $250K figure reflects the tax withholding sale proceeds, not an independent cash sale by the insider.

Insider Transaction Report

Form 4
Period: 2026-06-15
Carroll Patrick Harrison
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    [F1]
    2026-06-15+25,926213,897 total
  • Tax Payment

    Class A Common Stock

    [F2]
    2026-06-15$30.17/sh8,310$250,713205,587 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3]
    2026-06-158,14816,298 total
    Class A Common Stock (8,148 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F4]
    2026-06-154,84033,877 total
    Class A Common Stock (4,840 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F5]
    2026-06-153,53338,864 total
    Class A Common Stock (3,533 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F6]
    2026-06-159,405141,084 total
    Class A Common Stock (9,405 underlying)
Footnotes (6)
  • [F1]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
  • [F2]The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
  • [F3]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the Company's quarterly vesting dates occurring thereafter.
  • [F4]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2024.
  • [F5]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2025.
  • [F6]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Patrick Harrison Carroll|2026-06-17

Documents

1 file
  • 4
    wk-form4_1781736665.xmlPrimary

    FORM 4